Add-on Acquisition • Life Science

Allergan Acquires Kythera Pharmaceuticals

On October 1, 2015, Allergan acquired life science company Kythera Pharmaceuticals for 2.1B USD

Acquisition Context
  • This is Allergan’s 5th transaction in the Life Science sector.
  • This is Allergan’s 2nd largest (disclosed) transaction.
  • This is Allergan’s 14th transaction in the United States.
  • This is Allergan’s 8th transaction in California.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date October 1, 2015
Target Kythera Pharmaceuticals
Sector Life Science
Buyer(s) Allergan
Deal Type Add-on Acquisition
Deal Value 2.1B USD

Target Company

Kythera Pharmaceuticals

Westlake Village, California, United States
Kythera Pharmaceuticals is focused on the aesthetic medicine market, including its treatment for submental fullness (double chin).
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Allergan

Irvine, California, United States

Category Company
Founded 1948
Sector Life Science
Employees11,400
DESCRIPTION

Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.


Deal Context for Buyer #
Overall 14 of 14
Sector: Life Science 5 of 5
Type: Add-on Acquisition 13 of 13
State: California 8 of 8
Country: United States 14 of 14
Year: 2015 3 of 3
Size (of disclosed) 2 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-31 Naurex

Evanston, Illinois, United States

Naurex, Inc. is a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system.

Buy $560M